rongsheng cai md free sample

There is a star rating of 4/5 for Dr. Rongsheng Cai, MD. Patients say that they trusted the provider"s decisions and the provider explained conditions well. See all patient feedback on Sharecare.

rongsheng cai md free sample

Dr. Rongsheng Cai M.D. is a male health care provider in Tulsa with Neurological Surgeon listed as his primary medical specialization. His credentials are: M.D. (Doctor of Medicine). Dr. Rongsheng Cai M.D."s practice location is: 6151 S Yale Ave Ste 2403 Tulsa, OK 74136-1907.

The following links provides both mobile location-based directions and traditional directions to the office of Dr. Rongsheng Cai M.D. located at 6151 S Yale Ave Ste 2403 in Tulsa:

Are you a patient of Dr. Rongsheng Cai M.D. or familiar with their services? Please consider filling out our survey via the link below to help future patients make an informed decision.

Our Full Ratings Survey includes 3 main topics and 9 questions including staffing, wait times, appointment scheduling, billing, and more. We"d really appreciate it if you"re able to take a moment to leave your thoughts and feedback if you have had an office visit or appointment with Dr. Rongsheng Cai M.D..

The following profiles are additional Neurological Surgeon providers in Tulsa and / or near Dr. Rongsheng Cai M.D.. Profiles may include costs for specific services and procedures, common referrals, ratings, and reviews.

rongsheng cai md free sample

For Reprints please contact: Rongsheng E. Wang, Mediomics LLC, 5445 Highland Park Drive, St. Louis, MO, USA, ude.ltsuw@gnawgnehsgnor; Phone: 314-341-0544

20. Konecny GE, Pegram MD, Venkatesan N, et al. Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells. Cancer Res.2006;66:1630–9. [PubMed]

110. Cai W, Zhang Y, Kamp TJ. Imaging of induced pluripotent stem cells: from cellular reprogramming to transplantation. Am J Nucl Med Mol Imaging.2011;1:18–28. PubMed]

151. McLarty K, Cornelissen B, Cai Z, et al. Micro-SPECT/CT with 111In-DTPA-pertuzumab sensitively detects trastuzumab-mediated HER2 downregulation and tumor response in athymic mice bearing MDA-MB-361 human breast cancer xenografts. J Nucl Med.2009;50:1340–8. [PubMed]